ScripsAmerica, Inc. (OTCQB: SCRC) is a supplier of prescription, OTC and nutraceutical drugs, delivering pharmaceutical products to a wide range of end users across the health care industry. End users include retail pharmacies, hospitals, long-term care facilities and government and home care agencies. SNNLive spoke with Bob Schneiderman, ScripsAmerica, Inc. at the SeeThruEquity MicroCap Investor Conference 2014 in New York City, NY.
Mr. Schneiderman begins with an overview of the company, “ScripsAmerica is a public company, we distribute pharmaceuticals to independent pharmacies, we have distribution facilities in Florida as well as in Tennessee and we have a compounding pharmacy specially operation in Clifton, New Jersey.”
He explains the benefits of having a compounding facility, “Larger pharmacies and drug companies do not do custom type of product. The beauty and the advantage of compounding is it avoids having to use opiates or addicting type of pharmaceuticals which can cause problems and interactions and habits that are unfortunately not good habits with the patients. We specialize mostly in pain and scar creams and those creams are non-addicting, easy to apply and the results seem to be much much better, our case studies have shown that.”
He concludes by stating what ScripsAmerica is looking forward to in 2015-16, “Fortunately, on the upside we have shown tremendous growth since February this year, we are looking at expanding our facility and in addition to expanding our product line, also we have a product that we’re waiting for a final approval from our distributor in Hong Kong for a wrapping-made product which is an oral delivery technology product, our initial one is geared to children.” For more information, check out their website: www.ScripsAmerica.com
© 2017 Stock News Now
Supported by Superior Web Solutions